EUCTR2019-004557-92-DK进行中(未招募)1 期
Acute effects of Sodium-glucose coTRansporter-2 inhibition on renal OxygeNation and AUTonomic function in type 1 diabetes - Astronaut
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Inclusion criteria healthy controls:
- •Written informed consent must be provided before participation
- •Male or female patients >18 years of age with a diagnosis of type 1 diabetes (WHO criteria)
- •Capable of lying in a MR-scanner for two hours
- •Inclusion criteria persons with type 1 diabetes:
- •Written informed consent must be provided before participation
- •Male or female patients >18 years of age with a diagnosis of type 1 diabetes (WHO criteria)
- •Urinary albumin creatinine ratio (UACR) =30 mg/g in 2 out of 3 consecutive samples (albuminuria) prior to randomization assessed from electronic laboratory database.
- •Capable of lying in a MR-scanner for two hours
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 20
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 10
排除标准
- •Exclusion criteria for all:
- •Non-diabetic kidney disease as indicated by medical history and/or laboratory findings
- •Renal failure (eGFR<15 ml/min/1.73m2), dialysis or kidney transplantation
- •Treatment with beta-blocking medication
- •Uncontrolled arrhythmia, 2. or 3. degree AV-block or sick sinus syndrome - assessed from a standard 12-lead electrocardiogram
- •Pregnancy or breastfeeding (urine HCG is performed on all fertile women)
- •Systolic blood pressure < 90 or > 200 mmHg
- •Patients who, in the judgement of the investigator, is incapable of participating
- •Exclusion criteria for MRI
- •o Claustrophobia
- •o Known heart disease
- •o Known lung disease
- •o Have had surgery the past six weeks
- •o Have foreign bodies of metal in the body (e.g. pacemaker, metal plates, metal screws)
- •Exclusion criteria for arterial blood gas sampling
- •o Absent pulse
- •o Raynauds syndrome
- •o Buergers Disease (thromboangiitis obliterans)
- •o Inadequate or interrupted circulation
- •o Anticoagulation treatment
- •o Coagulopathies (hypo or hyper coagulable states)
- •o Arterial atherosclerosis
- •o Insufficient collateral perfusion
- •o Partial or full thickness burns over the cannulation site
- •o Synthetic arterial or vascular grafts or infection at the proposed site of cannulation
研究者
相似试验
尚未招募
Unknown
The effects Of sodium-glucose coTransporter 2 inhibiTOR on fastIng Hepatic Insulin Clearance in type 2 diabetesJPRN-jRCT1061230070Okura Tsuyoshi20
终止
不适用
Effects of Sodium Glucose Co-Transpoter-2 (SGLT-2) in diabetics with heart failureCardiovascular - Other cardiovascular diseasesMetabolic and Endocrine - DiabetesType 2 DiabetesHeart failureACTRN12618000795291Endcrinology Department, Box Hill Hospital - Eastern Health2
尚未招募
4 期
Effects of SGLT2 Inhibitor Therapy on Pancreatic and hepatic fat content in patients of Type 2 Diabetes MellitusCTRI/2019/08/020909ASTRA ZENECA PHARMACEUTICAL INDIA
已完成
不适用
Effects of sodium/glucose cotransporter 2 (SGLT2) inhibitors on metabolic parameters in patients with type 2 diabetes: A chart-based analysistype 2 diabetesJPRN-UMIN000020314ational Center for Global Health and Medicine Kohnodai Hospital75
已完成
4 期
Effect of SGLT2 inhibitors on heart function in type 2 diabetic patients in south IndiaCTRI/2020/02/023195izams Institute of Medical Sciences
